Letters
Shift work and cancer
Risk, compensation, challenges
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3430 (Published 25 August 2009) Cite this as: BMJ 2009;339:b3430
- Thomas C Erren, physician, epidemiologist1,
- Puran Falaturi, physician1,
- Peter Morfeld, epidemiologist1,
- Russel J Reiter, professor of neuroendocrinology2
- 1Institute and Policlinic for Occupational and Social Medicine, University of Cologne, 50924 Köln, Germany
- 2Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA
- tim.erren{at}uni-koeln.de
The group 2A classification by the International Agency for Research on Cancer (IARC) of shift work that entails circadian disruption as probably carcinogenic came—for many—as a surprise.1 Thereafter, with specific reference to IARC’s declaration, 38 women with breast cancer who had worked night shifts for at …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.